
â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—
â•‘         PHASE 1 COMPLETE - DATA PROCESSING SUMMARY            â•‘
â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

ğŸ“Š MERGED DATASET:
   Records: 24,772
   Columns: 81
   
ğŸ“ˆ COVERAGE:
   From 248k dataset: 10.0% (24,772 records)
   From 11k dataset: 209.5% (multiple matches/record)
   
ğŸ”— UNIQUE MEDICINES AVAILABLE:
   253,768 total
   - Matched: 24,772
   - Unmatched 248k: 224,240
   - Unmatched 11k: 4,756

âœ“ DATA QUALITY:
   Overall Completeness: 50.1%
   Critical Fields: 100% complete
   Side Effects: 16.0% populated
   Uses/Indications: 41.2% populated

ğŸ“ FILES CREATED:
   âœ“ medicines_merged.csv
   âœ“ medicines_unmatched_248k.csv
   âœ“ medicines_unmatched_11k.csv
   âœ“ merge_metadata.json
   âœ“ quality_report.json

ğŸš€ READY FOR PHASE 2:
   Feature Engineering
   ML Model Training (Symptom â†’ Medicine Classification)
   Ensemble Model Creation

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
